Abstract
Positron emission tomography (PET)-computed tomography (CT) is a useful device in identifying musculoskeletal lesions that require biopsy. It can be used to localize the primary lesion, identify a site to biopsy, and evaluate metastatic lesions that require follow-up biopsies. Not all malignant tumors have hypermetabolic activity, and there are many benign lesions and physiologic processes that do have increased F-18 fluorodeoxyglucose uptake. Knowledge of these issues is important when reviewing PET-CT and directing subsequent musculoskeletal biopsies.
Original language | English (US) |
---|---|
Pages (from-to) | 475-486 |
Number of pages | 12 |
Journal | Radiologic Clinics of North America |
Volume | 46 |
Issue number | 3 |
DOIs | |
State | Published - May 2008 |
Keywords
- Biopsy
- Musculoskeletal
- PET-CT
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging